Bayer Hemophilia Awards Program Bayer HealthCare
      ContactSitemapLanguage 
HomeAbout The Program
  Important updates
  Application Process
  Deadlines for Awards
  Review Process
  Research Priorities
  Past Award Recipients
  Past Award Recipients Archives
Bayer Links
   Bayer Global
   Bayer US
   Living with Haemophilia
   Kogenate FS
   General Conditions of Use
Regulatory Statement
Privacy Statement
Imprint




  2004 © Bayer HealthCare LLC

Past Award Recipients - 2003/2004

Clinical Scholarship Awardees

Dr. Yesim Dargaud
Centre de traitement de l'hemophilie, Hopital Edouard Herriot, Lyon, France
See Letter of Intent


Dr. Rekha Parameswaran Indiana Hemophilia and Thrombosis Center, Indiana, US
See Letter of Intent


Dr. Simona Siboni
A.Bianchi Bonomi, Hemophilia Thrombosis Center, Milan, Italy
See Letter of Intent




Early Career Investigator Awardees

Dr. Lingfei Xu
Washington University School of Medicine, St Louis, Missouri, USA
Project: Tolerance induction with neonatal gene therapy for hemophilia A
See Letter of Intent


Dr. Hengjun Chao Mount Sinai School of Medicine, NY, US
Project: Spliceosome-mediated RNA trans-splicing for hemophilia A gene therapy
See Letter of Intent


Dr. Suchitra Acharya
Weill Medical College of Cornell University, NY, US Project: Role of power Doppler sonography in hemophilic synovitis
See Letter of Intent


Dr. Beth Bouchard University of Vermont, Burlington, VT, US
Project: Identification of the megakaryocyte receptor that mediates endocytosis of Factor V from plasma
See Letter of Intent


Dr. Vince Jenkins
National Centre for Hereditary Coagulation Disorders, St James' Hospital & Trinity College, Dublin, Ireland
Project: Determination of the effect of haemophilia A mutations in the A3 and C1 domains of Factor VIII
See Letter of Intent


Dr. Andreas Tiede
Hannover Medical School, Germany
Project: Molecular engineering of coagulation Factor VIII
See Letter of Intent


Dr Annette Bowyer
Royal Hallamshire Hospital, Sheffield, UK
Project: The utility of different assays in the assessment of concentration of Factor VIII:C
See Letter of Intent


Dr. Shrimati D Shetty
Institute of Immunohaematology, Mumbai, India
Project: Thrombohaemorrhagic balance in hemophilia- implications for alternative therapeutic approach
See Letter of Intent




Hemophilia Caregivers Awardees

Pamela Hilliard
Hospital for Sick Children, Toronto, Ontario, Canada
Project: Hemophilia joint health score: instructional videotape
See Letter of Intent


Dr Rosie Roldan
University of Texas Health Science Center, San Antonio, TX, US
Project: Dental management of the patient with hemophilia
See Letter of Intent


Dr. Lisa Michaels UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, US
Project: Hemophilia healthcare adolescent to adult transition assessment
See Letter of Intent


Vicky Vidler Sheffield Children's Hospital, UK
Project: Essentials of advanced haemophilia nursing
See Letter of Intent


Dr. Sylvia von Mackensen
A. Bianchi Bonomi Haemophilia & Thrombosis Centre, Milan, Italy
Project: Specialisation programme for haemophilia nurses in Italy
See Letter of Intent


Dr. Anna Maria Bottos
Haemophilia Center -Azienda Ospedaliera di Padova, Italy
Project: ''I go to school''
See Letter of Intent


Dr. Cristina Mazzini
Haemophilia Center -Azienda Ospedaliera di Padova, Italy
Project: The psychological aspects of haemophilia
See Letter of Intent


Christine Peltier
Centre Hospitalier Universitaire, Bordeaux, France
Project: Freelance nurse's education
See Letter of Intent


Dr. Maria Vittoria Rizzo
A.R.N.A.S.- Children's Hospital, Palermo, Italy
Project: Listening centre plan for the haemophilic patient and his family
See Letter of Intent


Dr Sylvie Lacroix
Hôpital Sainte-Justine, Montréal, Québec, Canada
Project: Telemetry in the service of hemophiliac patients with coagulation inhibitors in Quebec
See Letter of Intent




Special Project Awardees

Dr. Jen-Yea (Peter) Chang University of North Carolina at Chapel Hill, NC, US
Project: Amelioration of hemophilia by manipulating the TFPI's activity
See Letter of Intent


Dr. Jacques Galipeau
Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
Project: Marrow stromal cells for transgenic cell therapy of hemophilia A
See Letter of Intent


Dr. Rainer Schwaab
Institute for Experimental Hematology and Transfusion Medicine, Bonn, Germany
Project: In silico design and in vitro validation of a mimotope for blocking an FVIII-inhibitor antibody
See Letter of Intent


Dr. Wolfgang Eugen Muntean
Ludwig Boltzmann Research Institute for Pediatric, Graz, Austria
Project: Hemophilia rarely becomes symptomatic during the neonatal period: biochemical background
See Letter of Intent


Professor Marguerite Neerman-Arbez
Department of Genetic Medicine and Development, CMU, Geneva, Switzerland
Project: Investigation of the molecular mechanisms regulating fibrinogen secretion
See Letter of Intent